The Econophy Group LLC is a private equity independent sponsor focused on the biotech space. Prospective candidate technologies are developed through a global JV with a team of MDs, PhDs, and industry-related CROs. Considered a "hidden champion", its design and features can be characterized as becoming the "gold standard for the IVD industry, on a worldwide basis. Specialties include pulmonary diseases; TB for impacted countries and a derivative focused on the impact of Particulate Matter (PM), which is generated from Climate Change. The technology has the efficacy attributes to replace the US industry standard MAA diagnostic, which is limited to 50 microns of detection.

As a private equity firm, we focus on growth capital opportunities that represent a myriad of liquidity events. Finance is seen as one of the industries most vulnerable to disruption by software because financial services, much like publishing, are made of bits rather than concrete goods. While finance has been shielded by regulation until now, and weathered the dot-com boom without major upheaval, a new wave of startups and emerging ventures is increasingly "disaggregating" global banks. When applying the criteria associated with our "hybrid PE fund model" ™ focused on the fintech evolution, we implement a rigid set of operating criteria. Our private equity portfolio candidates are well-established with their respective product offerings and/or services provided. Inclusively, they are capable of international expansion and developing a sustainable and rapid growth mode. Through our management team's industry network, we are presented a number of venture or firm introductions for equity participation consideration. The dominant characteristic of each is that they (1) solve a problem, and/or, (2) reduce costs. Following a company-specific investment process to evaluate the intrinsic value of the company based on the future relevancy of the company's products or services, sustainable competitive advantages and management, we apply nine operating standards to initiate a PE interest exploration and further the process through a capital commitment.